Ipamorelin is researched as a selective GHRP for growth hormone release with minimal cortisol/prolactin spillover in secretagogue models.
Research breakdown
- Primary research area
- Selective ghrelin receptor agonism and GH release research.
- Pathways studied
- GHS-R1a signalling with reduced off-target endocrine activation.
- Typical laboratory use
- Pituitary secretagogue panels and receptor selectivity assays.
For qualified in vitro and laboratory research use only. Not for human or veterinary consumption.
